Synthesis and anti-influenza virus activity of substituted dibenzoxepine-based baloxavir derivatives
- 28 September 2024
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 280, 116922
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Tackling Influenza A virus by M2 ion channel blockers: Latest progress and limitationsEuropean Journal of Medicinal Chemistry, 2024
- Synthesis and pharmacodynamic evaluation of naphthalene derivatives against influenza A virus in vitro and in vivoEuropean Journal of Medicinal Chemistry, 2023
- Conformationally locked sugar derivatives and analogues as potential neuraminidase inhibitorsEuropean Journal of Medicinal Chemistry, 2023
- Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion ReactionsJAMA Network Open, 2022
- Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020Antiviral Research, 2022
- Baloxavir Marboxil: A Review in Acute Uncomplicated InfluenzaDrugs, 2020
- Who and when to vaccinate against influenzaInternational Journal of Infectious Diseases, 2020
- Effect of influenza H1N1 neuraminidase V116A and I117V mutations on NA activity and sensitivity to NA inhibitorsAntiviral Research, 2019
- Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013–18Vaccine, 2019
- New small-molecule drug design strategies for fighting resistant influenza AActa Pharmaceutica Sinica B, 2015